Literature DB >> 3188615

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.

C O Tacket1, M M Levine, J B Robbins.   

Abstract

After a single injection of purified Vi polysaccharide vaccine against typhoid fever, serum titres were followed in student volunteers by passive haemagglutination assay and by radioimmunoassay. Elevated Vi antibody titres were still present after 36 months. This preliminary study should be followed by further investigations on the extent and duration of protection provided by Vi vaccine, and on volunteers in endemic areas.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3188615     DOI： 10.1016/0264-410x(88)90175-2

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  8 in total

1.  Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.

Authors:  Rémy Michel; Eric Garnotel; André Spiegel; Marc Morillon; Pierre Saliou; Jean-Paul Boutin
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children.

Authors:  Shousun C Szu; Keith P Klugman; Steven Hunt
Journal:  Vaccine       Date:  2014-03-13       Impact factor: 3.641

3.  Positive antibody response to vaccination in adolescence predicts lower C-reactive protein concentration in young adulthood in the Philippines.

Authors:  Thomas W McDade; Linda Adair; Alan B Feranil; Christopher Kuzawa
Journal:  Am J Hum Biol       Date:  2010-12-17       Impact factor: 1.937

Review 4.  Advances in vaccines for typhoid fever.

Authors:  A Gupta; S Jalla; S Sazawal; M K Bhan
Journal:  Indian J Pediatr       Date:  1994 Jul-Aug       Impact factor: 1.967

5.  Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.

Authors:  Christine Hale; Frances Bowe; Derek Pickard; Simon Clare; Jean-Francois Haeuw; Ultan Powers; Nathalie Menager; Pietro Mastroeni; Gordon Dougan
Journal:  Vaccine       Date:  2006-03-20       Impact factor: 3.641

6.  Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.

Authors:  R Leon Ochiai; M Imran Khan; Sajid B Soofi; Dipika Sur; Suman Kanungo; Young A You; M Atif Habib; Shah Muhammad Sahito; Byomkesh Manna; Shanta Dutta; Camilo J Acosta; Mohammad Ali; Sujit K Bhattacharya; Zulfiqar A Bhutta; John D Clemens
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

Review 7.  Vaccination against typhoid fever: present status.

Authors:  B Ivanoff; M M Levine; P H Lambert
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 8.  The need & the issues related to new-generation typhoid conjugate vaccines in India.

Authors:  Vipin M Vashishtha; Ajay Kalra
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.